Gemina Laboratories Ltd. (GLABF)

USD 0.74

(5.29%)

Market Cap (In USD)

55.17 Million

Revenue (In USD)

-

Net Income (In USD)

-5.21 Million

Avg. Volume

15.42 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.235-0.6504
PE
-18.42
EPS
-0.04
Beta Value
0.095
ISIN
CA3686501071
CUSIP
-
CIK
-
Shares
74863500.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Brian Firth
Employee Count
-
Website
https://www.geminalabs.com
Ipo Date
2022-03-29
Details
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops novel surface functionalization chemistries for the detection of pathogens and biomarkers. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. The company is headquartered in Vancouver, Canada.